Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 1/20 | 0.56 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ANPEP | P15144 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29978110 | 1.00 | PLAU (0.56) | PLAUMTNR1AMTNR1BHTR1AANPEP | |
| SCHEMBL15147099 | 1.00 | PLAU (0.56) | PLAUMTNR1AMTNR1BHTR1AANPEP | |
| SCHEMBL11863282 | 0.98 | PLAU (0.54) | PLAUMTNR1AMTNR1BHTR1AANPEP | |
| SCHEMBL15888992 | 0.86 | TSHR (0.50) | PLAUMTNR1AMTNR1BHTR1ATSHR | |
| SCHEMBL315647 | 0.82 | BRD4 (0.54) | PLAUTSHR | |
| Methane SCHEMBL27448869 | 0.79 | BRD4 (0.52) | PLAUTSHR | |
| SCHEMBL597327 | 0.77 | CYP2A6 (0.41) | TSHR | |
| SCHEMBL11145661 | 0.77 | DGAT1 (0.47) | — | |
| SCHEMBL7712799 | 0.76 | CYP2A6 (0.50) | MAOAMAOBTSHRCYP19A1 | |
| SCHEMBL5124383 | 0.76 | CHRM3 (0.41) | PLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109929328-B | Composite ink and preparation method and device thereof | TCL科技集团股份有限公司 | 2021-10-22 | — | — | CN | claimed |
| US-20200373508-A1 | ELECTROLUMINESCENT MATERIAL INK AND ELECTROLUMINESCENT DEVICE THEREOF | GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-11-26 | — | — | US | claimed |
| CN-108948865-B | Electroluminescent material ink and electroluminescent device thereof | 广东聚华印刷显示技术有限公司 | 2020-07-10 | — | — | CN | claimed |
| CN-109929328-A | A kind of compound ink and preparation method thereof, device | TCL集团股份有限公司 | 2019-06-25 | — | — | CN | claimed |
| CN-108948865-A | Electroluminescent material ink and its electroluminescent device | 广东聚华印刷显示技术有限公司 | 2018-12-07 | — | — | CN | claimed |
| WO-2000012082-A1 | FORMAMIDE COMPOUNDS AS THERAPEUTIC AGENTS | GLAXO GROUP LIMITED (GB) | 2000-03-09 | — | — | WO | claimed |
| EP-0160508-B1 | PHENOL DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-05-31 | — | — | EP | claimed |
| JP-2255627-A | — | — | None | — | — | JP | disclosed |
| JP-63002942-A | — | — | None | — | — | JP | disclosed |
| EP-3360175-B1 | FORMULATIONS COMPRISING AT LEAST TWO ORGANIC SEMICONDUCTING COMPOUNDS AND AT LEAST TWO SOLVENTS | MERCK PATENT GMBH (DE) | 2023-05-17 | — | — | EP | disclosed |
| US-11637257-B2 | Electroluminescent material ink and electroluminescent device thereof | GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO. LTD (CN) | 2023-04-25 | — | — | US | disclosed |
| US-20220402915-A1 | BCL-2 INHIBITORS | BEONE MEDICINES I GMBH (CH) | 2022-12-22 | — | — | US | disclosed |
| EP-3131897-B1 | FACTOR IXA INHIBITORS | MERCK SHARP & DOHME (US) | 2022-06-15 | — | — | EP | disclosed |
| EP-0058633-B1 | COMPOSITION CONTAINING AN ABRASIVE SUBSTRATE FOR THE CLEANING OF HARD SURFACES | Airwick AG (CH) | 1984-12-27 | — | — | EP | disclosed |
| EP-0036833-B1 | PROCESS FOR THE CLEANING OF TEXTIL MATERIAL | Airwick AG (CH) | 1984-04-11 | — | — | EP | disclosed |
| EP-0058633-A1 | Composition containing an abrasive substrate for the cleaning of hard surfaces | Airwick AG (CH) | 1982-08-25 | — | — | EP | disclosed |
| US-4336024-A | USING ORGANIC SOLVENTS | AIRWICK INDUSTRIES, INC. (US) | 1982-06-22 | — | — | US | disclosed |
| US-4334977-A | HYDROGEN DONOR SOLVENT AND HYDROGEN TRANSFER SOLVENT | MOBIL OIL CORPORATION (US) | 1982-06-15 | — | — | US | disclosed |
| EP-0036833-A1 | Process for the cleaning of textil material | Airwick AG (CH) | 1981-09-30 | — | — | EP | disclosed |
| US-4276305-A | INSECTICIDES, MITICIDES | HOFFMANN-LA ROCHE INC. (US) | 1981-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402915-A1 | BCL-2 INHIBITORS | BCL2, BCL2L1, BCL2L2 | PLAU 4258/4885MTNR1A 3876/4885MTNR1B 3204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.